SLC34A2 Antibody [ADC] - (Lifastuzumab Vedotin, Research Grade)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-44555
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
ADC
Antibody Source
Monoclonal Human IgG1
Concentration
LYOPH mg/ml
Product Specifications
Immunogen
SLC34A2 (Uniprot: O95436)
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Theoretical MW
145 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Description
This product is an Antibody-Drug Conjugate (ADC) for Research Use Only (RUO).
Lifastuzumab Vedotin is an ADC consisting of an anti-NaPi2b monoclonal antibody conjugated to the cytotoxic agent MMAE
This product is shipped at ambient temperature. Upon receipt, store immediately at -20C or lower for 12 months in a lyophilized state. - 80C for 3 months after reconstitution. Avoid repeated freeze-thaw cycles.
Lifastuzumab Vedotin is an ADC consisting of an anti-NaPi2b monoclonal antibody conjugated to the cytotoxic agent MMAE
This product is shipped at ambient temperature. Upon receipt, store immediately at -20C or lower for 12 months in a lyophilized state. - 80C for 3 months after reconstitution. Avoid repeated freeze-thaw cycles.
Scientific Data Images for SLC34A2 Antibody [ADC] - (Lifastuzumab Vedotin, Research Grade)
Flow Cytometry: Hu SLC34A2 mAb [ADC] - (Lifastuzumab Vedotin) [NBP3-44555]
Human NaPi2b CHO-S Cells were stained with SLC34A2 and negative control protein respectively, washed and then followed by PE and analyzed with FACSELISA: Hu SLC34A2 mAb [ADC] - (Lifastuzumab Vedotin) [NBP3-44555]
Immobilized Human SLC34A2, VLP at 5 ug/mL can bind SLC34A2 , EC50=0.06175 ug/mL.Flow Cytometry: Hu SLC34A2 mAb [ADC] - (Lifastuzumab Vedotin) [NBP3-44555]
Human NaPi2b HEK293 Cell Line were stained with SLC34A2and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 0.9793 ug/mL.Applications for SLC34A2 Antibody [ADC] - (Lifastuzumab Vedotin, Research Grade)
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
> 90% by SDS-PAGE and HPLC
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Preservative
No Preservative
Concentration
LYOPH mg/ml
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C in powder form. Store at -80C once reconstituted.
Background: SLC34A2
Alternate Names
NAPI-3B, NPTIIb, sodium/phosphate cotransporter 2B, solute carrier family 34 (sodium phosphate), member 2, type II sodium-dependent phosphate transporter 3b
Additional SLC34A2 Products
Product Documents for SLC34A2 Antibody [ADC] - (Lifastuzumab Vedotin, Research Grade)
Product Specific Notices for SLC34A2 Antibody [ADC] - (Lifastuzumab Vedotin, Research Grade)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...